Average Co-Inventor Count = 4.04
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (61 from 2,285 patents)
2. Audiovox Corporation (7 from 130 patents)
3. Allergan Sales, Inc. (1 from 228 patents)
4. Voxx International Corporation (1 from 131 patents)
5. Audivox Corporation (1 from 3 patents)
71 patents:
1. 10881608 - Biodegradable intravitreal tyrosine kinase implants
2. 10669265 - Pyridyl benzothiophenes as kinase inhibitors
3. 10633373 - Pyridyl benzothiophenes as kinase inhibitors
4. 10493082 - 4-pregenen-11β-17-21-triol-3,20-dione derivatives
5. 10076492 - Biodegradable intravitreal tyrosine kinase implants
6. 10011593 - Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
7. 9868726 - Pyridyl benzothiophenes as kinase inhibitors
8. 9820989 - Method of treating conditions with kinase inhibitors
9. 9758509 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
10. 9657005 - Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors
11. 9650366 - Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
12. 9567324 - Substituted nicotinamide derivatives as kinase inhibitors
13. 9433631 - 4-pregenen-11β-17-21-triol-3,20-dione derivatives
14. 9403803 - Indole-3-carboxamides as kinase inhibitors
15. 9388176 - Method of treating conditiions with kinase inhibitors